Glaxo chief executive angry over NYS AG lawsuit – Telegraph Tue, 8 Jun 2004 The significance of the lawsuit filed by NYS Attorney General, Eliot Spitzer, has infuriated Jean-Pierre Garnier, GlaxoSmithKline’s CEO. As Money.Telegraph (UK) reports (below), the AG suit carries a significance beyond the money sought. “Reputationally, however, the…
Screening for Mental Illness–A Diabolical, Profit-Enhancing Experiment Fri, 22 Oct 2004 Concerned citizen groups are joining our effort to stop the government from implementing a sweeping recommendation for lifetime screening for mental illness. If implemented, the first to be screened for hidden mental illness are America’s 52 million school children…
July 12, 2002 Duke Warning: Zyprexa-Diabetes Link FYI Since they arrived on the market in the 1990s, the so-called ‘atypicial’ antipsychotic drugs have been wrapped in controversy and promotional hype by drug companies and their paid professional spin masters who made bald claims about their “favorable side effect profile” referring…
Drug Tested in Gulf War Is Approved for Troops_NYT Thu, 6 Feb 2003 The New York Times reports that FDA has approved the drug, pyridostigmine bromide for use by the military. The drug had been used experimentally during the Gulf War in 1991. It has been the center of controversy…
Antidepressant Ban for Kids Puts Pressure On U.S. / Canada Mon, 15 Dec 2003 The British government ban for use of all but one SSRI antidepressant drug in children and teens (Dec 10, 2003) is reverberating wherever these drugs are widely prescribed. The action was taken after an independent committee…
Lead author of JAMA article rethinks positive Zoloft report – Guardian Wed, 1 Oct 2003 In August 2003, the Sertraline Pediatric Study Group reported: “Sertraline-treated patients experienced statistically significantly greater improvement than placebo.” Their report was published in the authoritative Journal of the American Medical Association (JAMA). The authors claimed…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
The risks of the drugs far outweigh their benefits, said Vera Sharav, president of the Alliance for Human Research Protection, a New York-based consumer advocacy group.
Below the New York Times provides a summary of Crawford's selective disclosure and concealment of his financial holdings while he was
Commissioner, noting Crawford's ignoble tenure:
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned…
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."
According to a investigative report issued by the Israeli Health Ministry, the doctors "conducted illegal and unethical testing on thousands of elderly patients for years.
